This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read 23andMe’s 8K filing here.
About 23andMe
23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.
Featured Stories
- Five stocks we like better than 23andMe
- How to Calculate Options Profits
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Why Invest in 5G? How to Invest in 5G Stocks
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How is Compound Interest Calculated?
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
